Walgreens Boots Alliance Inc (WBA)

Healthcare | Medical Pharmaceuticals
Income Statement (Quarterly) 2025-02-28 2024-11-30 2024-08-31 2024-05-31
Revenue 38,588,000,000 39,459,000,000 37,547,000,000 36,351,000,000
Cost of Revenue 31,654,000,000 32,680,000,000 31,294,000,000 29,892,000,000
Gross Profit 6,934,000,000 6,779,000,000 6,253,000,000 6,459,000,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 8,891,000,000 7,015,000,000 6,948,000,000 6,393,000,000
Operating Expenses 12,501,000,000 7,024,000,000 7,230,000,000 6,348,000,000
Operating Income -1,956,000,000 -236,000,000 -977,000,000 111,000,000
Interest Expense 129,000,000 122,000,000 131,000,000 113,000,000
Income Before Tax -4,246,000,000 -415,000,000 -998,000,000 251,000,000
Income Tax Expense -212,000,000 66,000,000 2,082,000,000 20,000,000
Net Income -2,853,000,000 -265,000,000 -3,005,000,000 344,000,000
Per Share
EPS -3.30 -0.31 -3.48 0.40
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Revenue 147,658,000,000 139,081,000,000 132,703,000,000 132,509,000,000 139,537,000,000
Cost of Revenue 121,134,000,000 112,009,000,000 104,437,000,000 104,442,000,000 111,520,000,000
Gross Profit 26,524,000,000 27,072,000,000 28,266,000,000 28,067,000,000 28,017,000,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 28,113,000,000 34,205,000,000 27,295,000,000 24,586,000,000 27,045,000,000
Operating Expenses 40,600,000,000 33,954,000,000 27,295,000,000 24,586,000,000 27,045,000,000
Operating Income -14,076,000,000 -6,882,000,000 4,385,000,000 2,342,000,000 1,312,000,000
Interest Expense 482,000,000 580,000,000 400,000,000 905,000,000 639,000,000
Income Before Tax -14,219,000,000 -5,386,000,000 3,985,000,000 1,995,000,000 743,000,000
Income Tax Expense 1,246,000,000 1,858,000,000 -30,000,000 667,000,000 360,000,000
Net Income -8,636,000,000 -3,080,000,000 4,337,000,000 2,542,000,000 456,000,000
Per Share
EPS -10.01 -3.57 5.02 2.94 0.52
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-08-31 2023-08-31 2022-08-31 2021-08-31
Assets
Cash and Cash Equivalents 1,319,000,000 728,000,000 1,358,000,000 1,193,000,000
Short Term Investments 1,790,000,000 11,000,000 1,114,000,000 0
Net Receivables 5,851,000,000 5,381,000,000 5,017,000,000 5,663,000,000
Inventory 8,320,000,000 8,257,000,000 8,353,000,000 8,159,000,000
Total Current Assets 18,335,000,000 15,503,000,000 16,902,000,000 15,814,000,000
Property Plant Equipment 30,108,000,000 33,253,000,000 32,988,000,000 34,141,000,000
Goodwill and Intangibles 28,479,000,000 41,822,000,000 33,010,000,000 22,358,000,000
Total Assets 81,037,000,000 96,628,000,000 90,124,000,000 81,285,000,000
Liabilities
Account Payables 14,082,000,000 12,635,000,000 11,255,000,000 11,136,000,000
Short Term Debt 2,456,000,000 3,265,000,000 3,345,000,000 3,565,000,000
Total Current Liabilities 26,953,000,000 24,535,000,000 22,583,000,000 22,054,000,000
Long Term Debt 29,882,000,000 30,269,000,000 32,132,000,000 29,828,000,000
Total Liabilities 68,857,000,000 68,138,000,000 59,716,000,000 57,463,000,000
Shareholders Equity
Retained Earnings 23,348,000,000 33,058,000,000 37,801,000,000 35,121,000,000
Total Shareholders Equity 10,445,000,000 20,021,000,000 29,366,000,000 23,419,000,000
Balance Sheet (Annual) 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Assets
Cash and Cash Equivalents 1,319,000,000 728,000,000 1,358,000,000 1,193,000,000 516,000,000
Short Term Investments 1,790,000,000 11,000,000 1,114,000,000 0 0
Net Receivables 5,851,000,000 5,381,000,000 5,017,000,000 5,663,000,000 7,132,000,000
Inventory 8,320,000,000 8,257,000,000 8,353,000,000 8,159,000,000 9,451,000,000
Total Current Assets 18,335,000,000 15,503,000,000 16,902,000,000 15,814,000,000 18,073,000,000
Property Plant Equipment 30,108,000,000 33,253,000,000 32,988,000,000 34,141,000,000 35,065,000,000
Goodwill and Intangibles 28,479,000,000 41,822,000,000 33,010,000,000 22,358,000,000 26,021,000,000
Total Assets 81,037,000,000 96,628,000,000 90,124,000,000 81,285,000,000 87,174,000,000
Liabilities
Account Payables 14,082,000,000 12,635,000,000 11,255,000,000 11,136,000,000 14,458,000,000
Short Term Debt 2,456,000,000 3,265,000,000 3,345,000,000 3,565,000,000 5,965,000,000
Total Current Liabilities 26,953,000,000 24,535,000,000 22,583,000,000 22,054,000,000 27,070,000,000
Long Term Debt 29,882,000,000 30,269,000,000 32,132,000,000 29,828,000,000 12,203,000,000
Total Liabilities 68,857,000,000 68,138,000,000 59,716,000,000 57,463,000,000 66,038,000,000
Shareholders Equity
Retained Earnings 23,348,000,000 33,058,000,000 37,801,000,000 35,121,000,000 34,210,000,000
Total Shareholders Equity 10,445,000,000 20,021,000,000 29,366,000,000 23,419,000,000 20,637,000,000
Cash Flow Statement (Quarterly) 2024-08-31 2023-08-31 2022-08-31 2021-08-31
Operating Activities
Net Income -15,448,000,000 -3,528,000,000 4,065,000,000 2,542,000,000
Depreciation & Amortization 2,459,000,000 2,257,000,000 1,990,000,000 1,973,000,000
Stock Based Compensation 182,000,000 385,000,000 391,000,000 155,000,000
Change in Working Capital -486,000,000 7,444,000,000 495,000,000 428,000,000
Operating Cash Flow 1,018,000,000 2,258,000,000 3,899,000,000 5,555,000,000
Investing Activities
Capital Expenditure -1,381,000,000 -2,117,000,000 -1,734,000,000 -1,379,000,000
Investments -1,381,000,000 -2,117,000,000 -1,734,000,000 -1,379,000,000
Investing Cash Flow 1,878,000,000 -3,094,000,000 -1,064,000,000 4,072,000,000
Financing Activities
Debt Repayment 889,000,000 -8,978,000,000 -8,360,000,000 -15,257,000,000
Common Stock Issued/Repurchased -69,000,000 6,170,000,000 -160,000,000 -110,000,000
Dividends Paid -1,260,000,000 -1,659,000,000 -1,659,000,000 -1,617,000,000
Financing Cash Flow -538,000,000 -887,000,000 -1,499,000,000 -9,036,000,000
Summary
Free Cash Flow -363,000,000 141,000,000 2,165,000,000 4,176,000,000
Net Change in Cash 2,362,000,000 -1,702,000,000 1,288,000,000 524,000,000
Cash Flow Statement (Annual) 2024-08-31 2023-08-31 2022-08-31 2021-08-31 2020-08-31
Operating Activities
Net Income -15,448,000,000 -3,528,000,000 4,065,000,000 2,542,000,000 456,000,000
Depreciation & Amortization 2,459,000,000 2,257,000,000 1,990,000,000 1,973,000,000 1,927,000,000
Stock Based Compensation 182,000,000 385,000,000 391,000,000 155,000,000 137,000,000
Change in Working Capital -486,000,000 7,444,000,000 495,000,000 428,000,000 941,000,000
Operating Cash Flow 1,018,000,000 2,258,000,000 3,899,000,000 5,555,000,000 5,484,000,000
Investing Activities
Capital Expenditure -1,381,000,000 -2,117,000,000 -1,734,000,000 -1,379,000,000 -1,374,000,000
Investments -1,381,000,000 -2,117,000,000 -1,734,000,000 -1,379,000,000 -1,374,000,000
Investing Cash Flow 1,878,000,000 -3,094,000,000 -1,064,000,000 4,072,000,000 -1,297,000,000
Financing Activities
Debt Repayment 889,000,000 -8,978,000,000 -8,360,000,000 -15,257,000,000 -21,414,000,000
Common Stock Issued/Repurchased -69,000,000 6,170,000,000 -160,000,000 -110,000,000 -1,589,000,000
Dividends Paid -1,260,000,000 -1,659,000,000 -1,659,000,000 -1,617,000,000 -1,747,000,000
Financing Cash Flow -538,000,000 -887,000,000 -1,499,000,000 -9,036,000,000 -4,647,000,000
Summary
Free Cash Flow -363,000,000 141,000,000 2,165,000,000 4,176,000,000 4,110,000,000
Net Change in Cash 2,362,000,000 -1,702,000,000 1,288,000,000 524,000,000 -461,000,000